This topic contains a solution. Click here to go to the answer
« previous next »

Author Question: What is the drug of choice in a patient with renal impairment who is being treated for a urinary ... (Read 55 times)

nautica902

  • Hero Member
  • *****
  • Posts: 591
on: Jul 23, 2018
What is the drug of choice in a patient with renal impairment who is being treated for a urinary tract infection (UTI)?
 
  A) Salazopyrin
  B) Silver sulfadiazine
  C) Declomycin
  D) Fosfomycin

Question 2

The nurse is caring for a patient who has indirect-acting cholinergic agonists prescribed to treat myasthenia gravis. When administering this classification of drug, the nurse should assess the patient for toxic effects of the drugs including what?
 
  A) Paralytic ileus
  B) Abdominal distension
  C) Hypertension
  D) Muscle weakness


Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Viet Thy

  • Sr. Member
  • ****
  • Posts: 329
Reply #1 on: Jul 23, 2018
Answer to Question 1

D
Feedback:
The dosage of fosfomycin, given orally, does not need to be changed in cases of renal impairment. It is the only medication listed here that is used in the treatment of urinary tract infections. Declomycin may be used to inhibit antidiuretic hormone in the treatment of chronic inappropriate antidiuretic hormone secretion. Salazopyrin is used in ulcerative colitis. Silver sulfadiazine is used topically to treat Pseudomonas infections.

Answer to Question 2

D
Feedback:
The patient with a cholinergic crisis presents with progressive muscle weakness and respiratory difficulty because the accumulation of acetylcholine at the cholinergic receptor site leads to reduced impulse transmission and muscle weakness. This is a crisis when the respiratory muscles are involved. Toxic effects of the drug would not include paralytic ileus, abdominal distention, or hypertension.


nautica902

  • Member
  • Posts: 591
Reply 2 on: Jul 23, 2018
Gracias!

mcabuhat

  • Member
  • Posts: 344
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

« previous next »
 

Did you know?

Most childhood vaccines are 90–99% effective in preventing disease. Side effects are rarely serious.

Did you know?

Hip fractures are the most serious consequences of osteoporosis. The incidence of hip fractures increases with each decade among patients in their 60s to patients in their 90s for both women and men of all populations. Men and women older than 80 years of age show the highest incidence of hip fractures.

Did you know?

Anesthesia awareness is a potentially disturbing adverse effect wherein patients who have been paralyzed with muscle relaxants may awaken. They may be aware of their surroundings but unable to communicate or move. Neurologic monitoring equipment that helps to more closely check the patient's anesthesia stages is now available to avoid the occurrence of anesthesia awareness.

Did you know?

The first oncogene was discovered in 1970 and was termed SRC (pronounced "SARK").

Did you know?

Interferon was scarce and expensive until 1980, when the interferon gene was inserted into bacteria using recombinant DNA technology, allowing for mass cultivation and purification from bacterial cultures.

Proper placement and monitoring of an automatic blood pressure cuff will reduce the risk of injury o Proper placement and monitoring of an automatic blood pressure cuff will reduce the risk of injury o
A pharmacist can explain to a patient why medication may look different and ensure the correct ... A pharmacist can explain to a patient why medication may look different and ensure the correct ...
Chest X-ray of a patient with emphysema. Chest X-ray of a patient with emphysema.
Promoting Adherence in the Older Adult Patient Promoting Adherence in the Older Adult Patient
Indirect enzyme immunoassay. A patient's antibody reacts with the antigen, which is detected ... Indirect enzyme immunoassay. A patient's antibody reacts with the antigen, which is detected ...
First-pass metabolism (biotransformation). Absorption of an orally administered drug. First-pass metabolism (biotransformation). Absorption of an orally administered drug.
Video: Ear Animation

For a complete list of videos, visit our video library